APA aipamena

Arora, S., Balasubramaniam, S., Zhang, H., Berman, T., Narayan, P., Suzman, D., . . . Beaver, J. A. (2020). FDA Approval Summary: Olaparib Monotherapy or in Combination with Bevacizumab for the Maintenance Treatment of Patients with Advanced Ovarian Cancer. Oncologist.

Chicago Style aipamena

Arora, Shaily, et al. "FDA Approval Summary: Olaparib Monotherapy or in Combination With Bevacizumab for the Maintenance Treatment of Patients With Advanced Ovarian Cancer." Oncologist 2020.

MLA aipamena

Arora, Shaily, et al. "FDA Approval Summary: Olaparib Monotherapy or in Combination With Bevacizumab for the Maintenance Treatment of Patients With Advanced Ovarian Cancer." Oncologist 2020.